Subcutaneous immunoglobulin in primary immunodeficiency – impact of training and infusion characteristics on patient-reported outcomes

Subcutaneous immunoglobulin in primary immunodeficiency – impact of training and infusion characteristics on patient-reported outcomes

Abstract Background Subcutaneous immunoglobulin (SCIG) is increasingly utilized in primary immunodeficiency (PI). Understanding factors associated with treatment experience and satisfaction can optimize patient outcomes. We analyzed Immune Deficiency Foundation (IDF) survey data to evaluate patient-...

Full description

Bibliographic Details
Main Authors: R. Mallick, T. Henderson, B. J. Lahue, A. Kafal, P. Bassett, C. Scalchunes
Format: Article
Language:English
Published: BMC 2020-08-01
Series:BMC Immunology
Subjects:
Primary immunodeficiency
Subcutaneous immunoglobulin (SCIG)
Patient reported outcomes
Treatment satisfaction questionnaire for medication (TSQM)
PROMIS fatigue
Infusion parameters
Online Access:http://link.springer.com/article/10.1186/s12865-020-00371-y

Similar Items

Similar Items